Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihai G Netea

Showing results (1181-1190 of 1,216) with videos related to

Pageof 122
Sort By:
STAR Protocols|March 15, 2021
<i>In vitro</i> induction of trained immunity in adherent human monocytesJorge Domínguez-Andrés, Rob J W Arts, Siroon Bekkering, et al.
Cytokine|December 18, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumoniaCharilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Journal of Fungi (Basel, Switzerland)|December 30, 2020
Polymorphisms within the <i>TNFSF4</i> and <i>MAPKAPK2</i> Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics ConsortiumJose Manuel Sánchez-Maldonado, Ana Moñiz-Díez, Rob Ter Horst, et al.
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
The Journal of Allergy and Clinical Immunology|December 18, 2020
Shared DNA methylation signatures in childhood allergy: The MeDALL studyCheng-Jian Xu, Olena Gruzieva, Cancan Qi, et al.
Clinical Immunology (Orlando, Fla.)|December 14, 2025
Long-term immune and epigenetic dysregulation following COVID-19Chrysanthi Sidiropoulou, Garyphallia Poulakou, Evdoxia Kyriazopoulou, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Pageof 122

Showing results (1181-1190 of 1,216) with videos related to

Sort By:
Pageof 122
STAR Protocols|March 15, 2021
<i>In vitro</i> induction of trained immunity in adherent human monocytesJorge Domínguez-Andrés, Rob J W Arts, Siroon Bekkering, et al.
Cytokine|December 18, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumoniaCharilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Journal of Fungi (Basel, Switzerland)|December 30, 2020
Polymorphisms within the <i>TNFSF4</i> and <i>MAPKAPK2</i> Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics ConsortiumJose Manuel Sánchez-Maldonado, Ana Moñiz-Díez, Rob Ter Horst, et al.
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
The Journal of Allergy and Clinical Immunology|December 18, 2020
Shared DNA methylation signatures in childhood allergy: The MeDALL studyCheng-Jian Xu, Olena Gruzieva, Cancan Qi, et al.
Clinical Immunology (Orlando, Fla.)|December 14, 2025
Long-term immune and epigenetic dysregulation following COVID-19Chrysanthi Sidiropoulou, Garyphallia Poulakou, Evdoxia Kyriazopoulou, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Pageof 122